For the Quarter Ending June 2023
North America
In the US, the prices of Levofloxacin Hemihydrate increased by 1.70 percent in June from the levels noticed in April. The US manufacturing PMI (Purchasing Managers Index) dropped to 46.3 in June, from 48.4 in May and 47.1 in April, suggesting limited inventories among market suppliers and traders accompanied by delays in delivery by suppliers to meet consumer demand, which supported the upward trend of prices of levofloxacin hemihydrate. Additionally, rising market sentiment was a result of an increase in consumer interest and a shortage of supply, which further compelled the traders to raise their quotations and concentrate on the restocking procedures. The consumer price index (CPI), an indicator of inflation, increased by 0.2% in June compared to 0.1% in May, suggesting inflation has slowed down in June due to a hike in interest rates by US Federal Reserve. Although the inflation rate was down, prices remained on the higher side, indicating more rate hikes were possible in the third quarter. Apart from that, the import momentum persisted at a consistent level, supporting the Levofloxacin Hemihydrate market trajectory in the second quarter.
Asia Pacific
In China, the prices of Levofloxacin Hemihydrate increased by 0.99 percent in June from the levels noticed in April. Levofloxacin Hemihydrate prices remained on the higher side in the second quarter due to increased demand from end consumers and fewer inventories among market providers. Moreover, higher upstream costs and restocking of inventories with fresh stock in order to cater to future demand further supported the Levofloxacin Hemihydrate market to remain strong. The official manufacturing Purchasing Managers' Index of China settled at 49.0 in June, from 48.8 in May and 49.2 in April, pointing out that factory activity had decreased for the third consecutive month resulting in less production activity. This caused a shortage of inventories in their warehouses amid a positive demand outlook, keeping the price on the higher side. Apart from that, the ongoing operational activity of plants coupled with rising inquiries from importers and traders resulted in higher production costs in the domestic market that further supported increased prices of levofloxacin hemihydrate across the Chinese market.
Europe
In Germany, the prices of Levofloxacin Hemihydrate increased by 2.04 percent in June from the levels noticed in April. Rising domestic demand coupled with overall supplies among the domestic merchants was the main driver of higher price realization for Levofloxacin Hemihydrate in the second quarter. Moreover, the market in Germany is further supported by new production in exporting nations in response to demand and high energy prices. Germany's manufacturing Purchasing Managers Index (PMI) fell to 41 in June, from 43.2 in May and 44.5 in April, reflecting lower business activity, fewer inventories among market traders and suppliers, and delays in shipments to meet demand, which led to higher prices for levofloxacin hemihydrate. Additionally, increasing demand from the end-use sector is further driving the upward trend in the price of levofloxacin hemihydrate. In addition, inflation increased by 6.4% in June, and energy prices rose by 3%, leading to higher costs for businesses relying on APIs (Active pharmaceutical ingredients), subsequently leading to higher prices of Levofloxacin hemihydrate.
For the Quarter Ending March 2023
North America
In the first quarter of 2023, the price of Levofloxacin Hemihydrate saw an upsurged trend. However, until February, the prices continued to grow on a positive note but declined at the same rate as the first quarter concluded in March 2023. Increase in domestic demand with limited supplies among market players, the price of Levofloxacin Hemihydrate has been on the rise until February 2023. By the termination of the first quarter, the consumer demand highlighted a weaker trend, due to which traders and local suppliers focused on placing the orders according to necessities. In addition to that, a slowdown in trade activity has additionally kept the market trend of Levofloxacin Hemihydrate in a downward direction. Overall, the cost of Levofloxacin Hemihydrate in the United States during the month of March was constructed at USD 66015/MT.
Asia Pacific
Prices for Levofloxacin Hemihydrate throughout the first quarter of 2023 showcased an inclined market trend. In early January, the market sentiments somewhat improved in China during the holiday-shortened month of January, primarily on account of improved demands following the Lunar New Year because both consumption and production increased significantly as the government abandoned its zero-COVID policy. A rise in domestic demand and inquiries from the international market further supported the overall market trend of Levofloxacin Hemihydrate until the mid of the first quarter of 2023. whereas, as March 2023 commenced, the prices of Levofloxacin Hemihydrate declined but stably, which was supported by a drop in domestic demand from downstream sectors coupled with sufficient stockpiles that can meet the overall necessities. With this, the prices of Levofloxacin Hemihydrate were settled at USD 63105/MT in China.
Europe
The prices of Levofloxacin Hemihydrate commenced the first half of the first quarter of 2023 on a bullish note on the back of a rise in orders from end-user sectors but ended on a tremendously bearish note. In early January, German consumer prices increased and continued to rise until the mid of the first quarter as a result of lowering inflation and decreased energy costs, which progressively boosted consumer confidence. Also, the market has started to show signals of strength in support of an improvement in the flow of commerce from China to Europe in comparison to the previous month, which has encouraged the overall market sentiments of Levofloxacin Hemihydrate in the German market. Nevertheless, orders from end-user industries were reduced, and the suppliers were left with enough inventories among themselves, keeping the market feeble towards the termination of the first quarter. With this, the prices of Levofloxacin Hemihydrate were assembled at USD 67145/MT in Germany.
For the Quarter Ending December 2022
North America
Throughout the last quarter of 2022, the North American region, particularly the United States market, showed declining pricing sentiments for Levofloxacin Hemihydrate. At the start of the fourth quarter, prices stayed relatively steady because demand inclined positively compared to the previous month. The different reasons that have affected the market for practically all commodities, including Levofloxacin Hemihydrate, are still closely monitored by market participants as fluctuating prices feared them for their losses. Until November, the prices held on the upper end due to lessening domestic market's overall supplies and healthy demand. With this, the price of Levofloxacin Hemihydrate was significantly demonstrated at USD 67220/MT CFR Los Angeles. After mod q-4 the prices of Levofloxacin Hemihydrate dropped considerably with the closure of the local market on account of New-year breaks.
Asia Pacific
With the end of the Final Quarter of 2022, Levofloxacin Hemihydrate prices in the Asia Pacific area, particularly in China, showed a considerable decline. Until November, China's biggest challenge was handling backed-up logistics on the main trade routes to North America and Europe due to restrictions on the export of all goods, including Levofloxacin Hemihydrate, which also had an impact on the price trends of this drug. In November, in the mid of the fourth quarter, Levofloxacin Hemihydrate prices were set at USD 61770/MT. Following the end of 2022, downstream demand and traders' quotations declined significantly, keeping the prices of Levofloxacin Hemihydrate on the south side.
Europe
During the fourth quarter of 2022, the prices of Levofloxacin Hemihydrate plummeted in the European region. October month witnessed a steadily incremented trajectory as end-user demand from the pharmaceutical sector for Levofloxacin Hemihydrate increased compared to the previous month, i.e., September. Until November, the prices inclined considerably with the settlement of USD 72580/MT CFR Hamburg in Germany and ended in December on the lower side. Furthermore, Levofloxacin Hemihydrate's price trend in November was additionally supported by the ease in supply chain interruption and shipping costs. However, as growing energy prices began to level down at the end of 2022, inflation in Europe declined in December for the second consecutive month, providing somewhat comfort in the prices of Levofloxacin Hemihydrate. On top of that, due to a decline in international orders, notably from exporting nations like China, demand decreased in December, positively supporting the market sentiments.
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the North American Region witnessed mixed sentiments. At the onset of the first half of Q3, the prices went down stably with sufficient supplies from the domestic merchants. Further, the prices rose significantly in the mid of q3 owing to increased downstream demand from the end-user sector and enough stocks with the suppliers to meet the overall demand side. Also, affected trading momentum from exporting countries impacted the market sentiments toward Levofloxacin Hemihydrate. Moreover, towards the termination of Q3, the prices showcased a decremented state again with the settlement of USD 63860/MT CFR Los Angeles in the united states.
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the APAC region witnessed a fluctuating trend owing to variable downstream demand and the supply side witness. In the first two months of q3, the prices rose significantly, leading to the shortage of stocks with the suppliers, which propelled them to increase their quotations. Additionally, disrupted trading activities leading to delayed shipments and rerouting momentum were another factor that supported the market sentiments of Levofloxacin Hemihydrate in the region. Furthermore, towards the termination of q3, the prices decreased considerably owing to weaker demand and enough supplies with the settlement of USD 56750/MT FOB Shanghai.
The European region witnessed similar market sentiments in the prices for Levofloxacin Hemihydrate as the APAC region, owing to heightened downstream demand in the market. Also, due to consistent offtakes from the domestic market amid rising input costs, the prices of Levofloxacin Hemihydrate inclined. Across Europe, rising energy costs due to the Russia-Ukraine conflict and the rerouting activities kept the market on the higher side. Furthermore, delayed exports from China due to Covid restrictions on transportation led to low inventories in the regional market till the mid of q3. Towards the termination of q3, the prices for Levofloxacin Hemihydrate went down significantly owing to decremented demand for sufficient supplies with the suppliers. The prices witnessed in September for Levofloxacin Hemihydrate settled at USD 67170/MT CFR Hamburg.
